338 related articles for article (PubMed ID: 11812941)
21. Two novel gross deletions of TSC2 in Malaysian patients with tuberous sclerosis complex and TSC2/PKD1 contiguous deletion syndrome.
Ismail NF; Nik Abdul Malik NM; Mohseni J; Rani AM; Hayati F; Salmi AR; Narazah MY; Zabidi-Hussin ZA; Silawati AR; Keng WT; Ngu LH; Sasongko TH
Jpn J Clin Oncol; 2014 May; 44(5):506-11. PubMed ID: 24683199
[TBL] [Abstract][Full Text] [Related]
22. Concurrent Reduced Expression of Contiguous
Meguro S; Koguchi T; Hakozaki Y; Onagi A; Matsuoka K; Hoshi S; Hata J; Sato Y; Akaihata H; Kataoka M; Ogawa S; Kojima Y
Cancer Genomics Proteomics; 2023; 20(1):40-50. PubMed ID: 36581342
[TBL] [Abstract][Full Text] [Related]
23. Complete inactivation of the TSC2 gene leads to formation of hamartomas.
Au KS; Hebert AA; Roach ES; Northrup H
Am J Hum Genet; 1999 Dec; 65(6):1790-5. PubMed ID: 10577937
[No Abstract] [Full Text] [Related]
24. Insight into response to mTOR inhibition when PKD1 and TSC2 are mutated.
Cabrera-López C; Bullich G; Martí T; Català V; Ballarín J; Bissler JJ; Harris PC; Ars E; Torra R
BMC Med Genet; 2015 Jun; 16():39. PubMed ID: 26077033
[TBL] [Abstract][Full Text] [Related]
25. Whole Exome Sequencing Identifies TSC1/TSC2 Biallelic Loss as the Primary and Sufficient Driver Event for Renal Angiomyolipoma Development.
Giannikou K; Malinowska IA; Pugh TJ; Yan R; Tseng YY; Oh C; Kim J; Tyburczy ME; Chekaluk Y; Liu Y; Alesi N; Finlay GA; Wu CL; Signoretti S; Meyerson M; Getz G; Boehm JS; Henske EP; Kwiatkowski DJ
PLoS Genet; 2016 Aug; 12(8):e1006242. PubMed ID: 27494029
[TBL] [Abstract][Full Text] [Related]
26. Renal disease in tuberous sclerosis complex: pathogenesis and therapy.
Lam HC; Siroky BJ; Henske EP
Nat Rev Nephrol; 2018 Nov; 14(11):704-716. PubMed ID: 30232410
[TBL] [Abstract][Full Text] [Related]
27. Renal angiomyolipomas, cysts, and cancer in tuberous sclerosis complex.
Neumann HP; Schwarzkopf G; Henske EP
Semin Pediatr Neurol; 1998 Dec; 5(4):269-75. PubMed ID: 9874854
[TBL] [Abstract][Full Text] [Related]
28. Infantile spasms and early-onset progressive polycystic renal lesions associated with TSC2/PKD1 contiguous gene deletion syndrome.
Matsubara Y; Akamine S; Chong PF; Kawakami S; Maehara K; Kaku Y; Kurokawa M; Morisada N; Iijima K; Kira R
Seizure; 2021 Mar; 86():82-84. PubMed ID: 33581549
[No Abstract] [Full Text] [Related]
29. Evidence that lymphangiomyomatosis is caused by TSC2 mutations: chromosome 16p13 loss of heterozygosity in angiomyolipomas and lymph nodes from women with lymphangiomyomatosis.
Smolarek TA; Wessner LL; McCormack FX; Mylet JC; Menon AG; Henske EP
Am J Hum Genet; 1998 Apr; 62(4):810-5. PubMed ID: 9529362
[TBL] [Abstract][Full Text] [Related]
30. Beyond polycystic kidney disease.
Santos SF; Francisco T; Cordeiro AI; Lopes MJP
BMJ Case Rep; 2017 Oct; 2017():. PubMed ID: 28978585
[TBL] [Abstract][Full Text] [Related]
31. Gross genomic rearrangement involving the TSC2-PKD1 contiguous deletion syndrome: characterization of the deletion event by quantitative polymerase chain reaction deletion assay.
Boehm D; Bacher J; Neumann HP
Am J Kidney Dis; 2007 Jan; 49(1):e11-21. PubMed ID: 17185137
[TBL] [Abstract][Full Text] [Related]
32. Tuberin-dependent membrane localization of polycystin-1: a functional link between polycystic kidney disease and the TSC2 tumor suppressor gene.
Kleymenova E; Ibraghimov-Beskrovnaya O; Kugoh H; Everitt J; Xu H; Kiguchi K; Landes G; Harris P; Walker C
Mol Cell; 2001 Apr; 7(4):823-32. PubMed ID: 11336705
[TBL] [Abstract][Full Text] [Related]
33. Chromosomal assignment of canine TSC2, PKD1 and CLN3 genes by radiation hybrid- and linkage analyses.
Jónasdóttir TJ; Mellersh CS; Moe L; Vignaux F; Ostrander EA; Lingaas F
Anim Genet; 2000 Apr; 31(2):123-6. PubMed ID: 10782211
[TBL] [Abstract][Full Text] [Related]
34. Tuberous sclerosis and the kidney: from mesenchyme to epithelium, and beyond.
Henske EP
Pediatr Nephrol; 2005 Jul; 20(7):854-7. PubMed ID: 15856327
[TBL] [Abstract][Full Text] [Related]
35. Tuberin regulates E-cadherin localization: implications in epithelial-mesenchymal transition.
Barnes EA; Kenerson HL; Jiang X; Yeung RS
Am J Pathol; 2010 Oct; 177(4):1765-78. PubMed ID: 20813961
[TBL] [Abstract][Full Text] [Related]
36. Molecular genetic and phenotypic analysis reveals differences between TSC1 and TSC2 associated familial and sporadic tuberous sclerosis.
Jones AC; Daniells CE; Snell RG; Tachataki M; Idziaszczyk SA; Krawczak M; Sampson JR; Cheadle JP
Hum Mol Genet; 1997 Nov; 6(12):2155-61. PubMed ID: 9328481
[TBL] [Abstract][Full Text] [Related]
37. Lessons from histopathologic examination of nephrectomy specimens in patients with tuberous sclerosis complex: cysts, angiomyolipomas, and renal cell carcinoma.
Gupta S; Stanton ML; Reynolds JP; Whaley RD; Herrera-Hernandez L; Jimenez RE; Cheville JC
Hum Pathol; 2022 Nov; 129():123-139. PubMed ID: 36115585
[TBL] [Abstract][Full Text] [Related]
38. Polycystin-1 expression in PKD1, early-onset PKD1, and TSC2/PKD1 cystic tissue.
Ong AC; Harris PC; Davies DR; Pritchard L; Rossetti S; Biddolph S; Vaux DJ; Migone N; Ward CJ
Kidney Int; 1999 Oct; 56(4):1324-33. PubMed ID: 10504485
[TBL] [Abstract][Full Text] [Related]
39. Reprint of: lessons from histopathologic examination of nephrectomy specimens in patients with tuberous sclerosis complex: cysts, angiomyolipomas & renal cell carcinoma.
Gupta S; Stanton ML; Reynolds JP; Whaley RD; Herrera-Hernandez L; Jimenez RE; Cheville JC
Hum Pathol; 2023 Mar; 133():136-152. PubMed ID: 36894367
[TBL] [Abstract][Full Text] [Related]
40. Molecular analysis of TSC2/PKD1 contiguous gene deletion syndrome.
Oyazato Y; Iijima K; Emi M; Sekine T; Kamei K; Takanashi J; Nakao H; Namai Y; Nozu K; Matsuo M
Kobe J Med Sci; 2011 Jun; 57(1):E1-10. PubMed ID: 22169896
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
